-
Follow the Money: Using AI for Clinical Enrollment, Pan-KRAS Degrader Trial, MoreBy Clinical Research Staff
Clinical Research News | Mendra aims to employ AI to accelerate patient identification and clinical trial enrollment; PAQ Therapeutics will advance its ongoing Phase 1 development of PT0253, PAQ's KRAS G12D degrader; and more.
Jan 28, 2026
-
Mount Sinai Connects Cancer Patients with Trials, Molecular Testing in Sub-Saharan Africa, Medable Announces TMF Agent
Clinical Research News | The Mount Sinai Tisch Cancer Center has launched a new artificial intelligence platform; Cytespace expanded its molecular testing capabilities to meet rising demand across Sub-Saharan Africa; Medable announced its TMF Agent; and more.
Jan 27, 2026
-
ESG Is Becoming a Clinical Operations Accountability
Clinical Research News | Clinical operations leaders are being asked to deliver faster, more complex trials while carrying Environmental, Social, and Governance (ESG) commitments they do not directly control. That tension is no longer theoretical. As supplier sustainability performance becomes a material driver of execution risk, quality, and delivery speed, ESG is quietly shifting from a corporate reporting obligation to a clinical operations accountability.
Jan 26, 2026
-
Why Clinical Trial Operations is the Place to Start with AI
Clinical Research News | Clinical trials are foundational to all breakthrough therapies, yet they are mired in operational quicksand—particularly study startup inefficiencies. According to WCG’s 2025 Site Challenges Report, nearly one-third of respondents ranked study startup issues around contracts, budgets, and system builds as the leading problem slowing clinical trials while nearly 20% cite trial financial management (payments) as a topmost burden.
Jan 23, 2026






